Partner Content Partner Content Key Questions To Boost Your KOL Management– Part 1/8: KOL Id... Introduction to KOL identification and it's value
Partner Content Partner Content Validating Your KOLs Validating your KOLs for an evolving KOL landscape
Partner Content Partner Content The Problem of the Hyperprolific Author When It Comes to KOL... The dangers of hyper-prolific authors
Patients New Boehringer US Head Brian Hilberdink talks GLP-1s, DTx an... At Reuters Pharma USA, editor-in-chief Jonah Comstock caught up with Brian Hilberdink, the new head of US human pharma at Boehringer Ingelheim.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
